Archived story3 articles · 3 publishers
FTC seeks contempt for Martin Shkreli over pharma ban violations
- Published
- Updated
- Reports
- 3 from 3 publishers
The Federal Trade Commission and a coalition of seven states asked a federal court to hold Martin Shkreli in contempt for "flagrantly and repeatedly" violating a lifetime ban from the pharmaceutical industry. The filing was made in the U.S. District Court for the Southern District of New York.
AI summary · Original reporting is linked alongside
How the outlets frame it
3 outlets, each read from its own headline and opening- All measuresNo outlet stands apart. Most read as neutral and mildly sensational.
Tap a logo to see the outlet, the headline it was read from, and where it sits on every measure.
Does the report cast the development as bad news or good news?
Both read as neutral.
1 outlet not placed: the reading was split between distant levels.
Does the report play the story up to grab attention?
Between measured and mildly sensational; no outlet stands apart.
Do the words judge rather than describe?
Between neutral wording and some charged words; no outlet stands apart.
All 3 outlets and the headlines they were read from
New York Post
‘Pharma Bro’ Martin Shkreli broke lifetime ban on drug industry trades, feds sayFraming: Neutral · Sensationalism: Mildly sensational · Loaded language: Neutral wording · Slant: not placed
The Hill
FTC: ‘Pharma bro’ Shkreli violated lifetime industry ban, should be held in contemptFraming: not placed · Sensationalism: Mildly sensational · Loaded language: Some charged words · Slant: not placed
ZeroHedge
FTC Seeks To Hold Martin Shkreli In Contempt For Allegedly Violating Lifetime Pharmaceutical Industry BanFraming: Neutral · Sensationalism: Measured · Loaded language: Some charged words · Slant: not placed
Each outlet is read blind: a classifier sees its headline and opening next to the story's own headline, without the outlet's name, and scores how the report presents the story. A logo sits at the classifier's average reading, so it can fall between two levels. These readings compare coverage of this story only; they are not ratings of the outlets.
The story as a whole
Read from all the reports togetherAffects a specific US group
Single event
No time pressure
Not disputed in the text
Official statement or press release
Attributed to named officials or documents
Not political
No violence reported
Other signals
9 found · 13 not present- Article typeNews report
- TopicCourts and legal
- Government levelMultiple levels
- Where it happensUnited States national
- What a reader getsNew facts
- ToneNeutral and factual
- Viewpoints presentedOne viewpoint only
- Main political actorA government agency
- Public healthA treatment or drug
- Policy areanot present
- Civil liberties questionnot present
- Market relevancenot present
- Which marketunclear
- Market horizonnot present
- Who is economically affectednot present
- Corporate dimensionnot present
- Conflict dimensionnot present
- Conflict direction reportednot present
- Humanitarian impactnot present
- Public safetynot present
- Scientific evidencenot present
- Legal risk in the reportingnot present
The 10 stories everyone is covering, in your inbox at 7 am your time.
grouped.news is free, independent and has no paywall. If it saves you time, chip in.Buy us a coffee ↗